SCG
CELG

Strategic Capital Group’s Celgene Corp CELG Stock Holding History

Strategic Capital Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$62K Sell
718
-200
-22% -$15.2K 0.02% 196
2014
Q1 		$64K Buy
+918
New +$72.7K 0.02% 205
2013
Q4 		– Sell
-760
Closed -$59K – 271
2013
Q3 		$59K Hold
760
– – 0.02% 194
2013
Q2 		$44K Buy
+760
New +$45.7K 0.02% 184

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Strategic Capital Group's CELG Position: Q2 2014 in Review

Strategic Capital Group reduced its Celgene Corp (CELG) stake by 22% in Q2 2014, selling an estimated $15.2K and leaving 718 shares worth $62K. The position accounts for 0.02% of the portfolio, ranked #196.

Strategic Capital Group first reported a position in CELG in Q2 2013 and has held it in 4 quarters since. The position peaked at $64K in Q1 2014. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Strategic Capital Group held 718 shares of Celgene Corp worth $62K as of Q2 2014.
  • Strategic Capital Group sold 200 Celgene Corp shares in Q2 2014, an estimated $15.2K.
  • Celgene Corp made up 0.02% of Strategic Capital Group's portfolio in Q2 2014, its #196 holding.
  • Strategic Capital Group first reported a position in Celgene Corp in Q2 2013 and has held it in 4 quarters since.
  • Strategic Capital Group's Celgene Corp position peaked at $64K in Q1 2014.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Strategic Capital Group's 13F filing for Q2 2014, filed 14 Jul 2014.